Swiss Life Asset Management Ltd Raises Stock Holdings in Kenvue Inc. $KVUE

Swiss Life Asset Management Ltd raised its holdings in Kenvue Inc. (NYSE:KVUE) by 17.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 366,012 shares of the company’s stock after purchasing an additional 54,131 shares during the period. Swiss Life Asset Management Ltd’s holdings in Kenvue were worth $5,940,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. American Century Companies Inc. raised its stake in shares of Kenvue by 22.4% during the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after buying an additional 6,781,640 shares during the period. Independent Franchise Partners LLP grew its stake in Kenvue by 233.4% in the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock valued at $654,388,000 after acquiring an additional 21,886,537 shares during the period. Norges Bank acquired a new stake in Kenvue in the 2nd quarter valued at $537,418,000. Dimensional Fund Advisors LP increased its holdings in Kenvue by 13.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 23,127,234 shares of the company’s stock worth $375,377,000 after acquiring an additional 2,747,952 shares in the last quarter. Finally, Van ECK Associates Corp increased its holdings in Kenvue by 101.3% in the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock worth $298,008,000 after acquiring an additional 9,240,434 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on KVUE. Argus upgraded shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Citigroup raised their price target on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Finally, UBS Group lifted their price objective on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Three investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $19.58.

Kenvue Trading Down 0.0%

Shares of KVUE stock opened at $17.43 on Friday. The stock’s fifty day moving average is $17.97 and its two-hundred day moving average is $17.19. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. The firm has a market capitalization of $33.40 billion, a P/E ratio of 22.63, a PEG ratio of 3.95 and a beta of 0.51. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.26 earnings per share. Research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s payout ratio is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.